Searchable abstracts of presentations at key conferences in endocrinology

ea0063p360 | Thyroid 1 | ECE2019

Changing practice in the management of differentiated thyroid carcinoma – experience at Brugmann Hospital in Brussels

Laura Iconaru , Felicia Baleanu , Rafik Karmali , Ruth Duttmann , Pierre Bergmann , Linda Spinato , Sophie Hambye Anne

Aim of the work: In patients with differentiated thyroid cancer, the basic goal of the therapy is to improve overall and disease-specific survival, reduce the risk of persistent/recurrent disease while minimizing treatment-related morbidity and unnecessary therapy. In 2015, the American Thyroid Association (ATA) published evidence-based guidelines for the staging and management of differentiated thyroid cancer, including the possibility of avoiding systematic complementary 131...

ea0073pep6.4 | Presented ePosters 6: Calcium and Bone | ECE2021

A rare cause of persistent hyperparathyroidism

Laura Iconaru , Linda Spinato , Ruth Duttmann , Hambye Anne-Sophie , Arnaud Devriendt , Maxime Herchuelz , Celine Mathey , Rafik Karmali , Pierre Bergmann

Ectopic parathyroid tissue remains a significant hurdle in the surgical management of hyperparathyroidism. In diagnostically challenging cases of persistent hyperparathyroidism, unusual ectopic locations of parathyroid adenomas must be considered in order to avoid numerous re-operative explorations and the associated risks to the patient. We present a 30-year-old female was referred to the endocrinology department for symptomatic hypercalcemia. Routine laboratory investigation...

ea0079005 | Abstracts | BES2021

Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study

Felicia Baleanu , Michel Moreau , Alexia Charles , Laura Iconaru , Rafik Karmali , Murielle Surquin , Florence Benoit , Aude Mugisha , Marianne Paesmans , Michel Rubinstein , Serge Rozenberg , Pierre Bergmann , Jean- Jacques Body

Context: Individualized fracture risk may help to select patients requiring a pharmacological treatment for osteoporosis. FRAX and the Garvan fracture risk calculators are the most used tools, though their external validation has shown significant differences in their risk prediction ability.Objective and Methods: Using data from the FRISBEE study, a cohort of 3560 post-menopausal women aged 60-85 years, we aimed to construct original 5-year fracture ris...